ABBOTT LABORATORIES (ABT)

Pharmaceutical Preparations

Latest Price

$103.09

TTM P/E

28.88

Normalized P/E

22.86

Div Yield

2.37%

Book Value

29.88

P/B Ratio

3.45

Valuation metrics

EPS: $3.72

Book value / share: $29.82

Formula: √(22.5 × EPS × BVPS)

Graham Number

$49.96

52% downside

Norm. op. income: $6.8B (median of 7yr)

Tax rate: 14%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$31.29

70% downside

Base FCF: $7.4B (median of recent 5yr)

Growth: 21%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$228.56

+122% upside

EPS: $3.72

Target P/E: 23×

Formula: EPS × P/E

P/E Fair Value

$85.56

17% downside

82.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	152.56M	$13.84B	8.76%	+6.77M	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	113.75M	$10.32B	6.53%	+801.1K	2026-06-30
STATE STREET CORP	80.93M	$7.34B	4.64%	+1.35M	2026-06-30
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	59.67M	$5.41B	3.42%	+14.17M	2026-06-30
Sixth Street Partners Management Company, L.P.	59.67M	$5.41B	3.42%	--	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	49.02M	$4.45B	2.81%	+1.07M	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	39.22M	$3.54B	2.25%	+70.5K	2026-06-30
Capital Research Global Investors	36.91M	$3.35B	2.12%	-12.87M	2026-06-30
Capital International Investors	34.65M	$3.15B	1.99%	-2.84M	2026-06-30
MORGAN STANLEY	26.61M	$2.41B	1.53%	-3.49M	2026-06-30